Advances in the diagnosis of heparin-induced thrombocytopenia
Expires: Mar 18, 2023
In this month’s “Virtual Lecture,” Anand Padmanabhan, M.B.B.S., Ph.D., provides an overview of diagnostic testing for heparin-induced thrombocytopenia (HIT) with an emphasis on recent advances in functional HIT testing.
Anand Padmanabhan, M.B.B.S., Ph.D.
Consultant, Divisions of Hematopathology and Transfusion Medicine
Mayo Clinic, Rochester, MN
Upon completion of this activity, participants should be able to:
This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.
The following types of credit are offered for this event:
Level of instruction for this program is intermediate.
To obtain credit:
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 0.5 P.A.C.E.® contact hour.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Contact us: email@example.com